ArticleInternal medicine (Tokyo, Japan)2021

A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.

Yukino Yatsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.